Tumor Registry of Advanced Renal Cell Carcinoma

NCT00610012 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2020-05-27

No results posted yet for this study

Summary

The purpose of this registry is to record information of therapy reality of metastatic or locally advanced Renal Cell Carcinoma by office-based medical oncologists in Germany.

Conditions

Sponsors & Collaborators

  • Arbeitskreis Klinische Studien

    collaborator OTHER
  • Bund der Urologen e.G.

    collaborator UNKNOWN
  • iOMEDICO AG

    lead INDUSTRY

Principal Investigators

  • Goebell Peter, MD · Waldkrankenhaus St. Marien, Erlangen, Germany

  • Lothar Müller, MD · Onkologie Leer - Emden - Papenburg, Germany

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-12-31
Primary Completion
2020-05-15
Completion
2020-05-15

Countries

  • Germany

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00610012 on ClinicalTrials.gov